Rare Cancer Clinical Trials in Heidelberg
3 recruitingHeidelberg, Germany
Showing 1–3 of 3 trials
Recruiting
Phase 4
Dabrafenib and/or Trametinib Rollover Study
MelanomaNon-small Cell Lung CancerSolid Tumor+2 more
Novartis Pharmaceuticals100 enrolled29 locationsNCT03340506
Recruiting
Treatment Guided by Comprehensive Genome and Transcriptome Analysis Versus Standard of Care in Advanced Rare Cancers
Rare Cancer
German Cancer Research Center946 enrolled16 locationsNCT06855134
Recruiting
Molecularly Aided Stratification for Tumor Eradication Research
MultiomicsRare Cancers
German Cancer Research Center10,000 enrolled1 locationNCT05852522